156 Dark immunopeptidome of head and neck squamous cell carcinoma in serial cell lines from a single patient during multimodality treatment time-course
Ryan Meng(Providence Portland Medical Center), Bernard A. Fox(Oregon Health & Science University), Christopher Paustian(UbiVac (United States)), Noriko Iwamoto(Shimadzu (Japan)), Alexa K. Dowdell(Providence Portland Medical Center), Walter J. Urba(Providence Portland Medical Center), Yuriko Minegishi(National Institutes of Health), Koji Ueda(RIKEN Center for Integrative Medical Sciences), Tarsem Moudgil(Providence Portland Medical Center), R. Bryan Bell(Takara (United States)), Shawn M. Jensen(Providence Portland Medical Center), Hong‐Ming Hu(Viva Biotech (China)), Venkatesh Rajamanickam(Cancer Institute (WIA)), Carlo Bifulco(Providence Health & Services), Rom S. Leidner(Providence Portland Medical Center), Ashish Patel(Providence Portland Medical Center), Traci Hilton(UbiVac (United States)), Yoshinobu Koguchi(Providence Portland Medical Center), Brian Piening(Providence College), Takashi Shimada(Keio University), Eric Tran(Providence Portland Medical Center), Tanisha Christie(Providence Portland Medical Center), William L. Redmond(Providence St. Vincent Medical Center)
Cited by 0
Related Papers
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
|Journal of Clinical Investigation|2004|1.4k
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
Longitudinal multi-omics of host–microbe dynamics in prediabetes
|Nature|2019|620